Preclinical Evaluation of M30 and M65 ELISAs as Biomarkers of Drug Induced Tumor Cell Death and Antitumor Activity
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-07-2136
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2008
Authors
Publisher
American Association for Cancer Research (AACR)